chr19-45380010-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006663.4(PPP1R13L):c.*180T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00531 in 677,488 control chromosomes in the GnomAD database, including 95 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 74 hom., cov: 31)
Exomes 𝑓: 0.0021 ( 21 hom. )
Consequence
PPP1R13L
NM_006663.4 3_prime_UTR
NM_006663.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.681
Genes affected
PPP1R13L (HGNC:18838): (protein phosphatase 1 regulatory subunit 13 like) IASPP is one of the most evolutionarily conserved inhibitors of p53 (TP53; MIM 191170), whereas ASPP1 (MIM 606455) and ASPP2 (MIM 602143) are activators of p53.[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 19-45380010-A-G is Benign according to our data. Variant chr19-45380010-A-G is described in ClinVar as [Benign]. Clinvar id is 1276848.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0552 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPP1R13L | NM_006663.4 | c.*180T>C | 3_prime_UTR_variant | 13/13 | ENST00000360957.10 | ||
PPP1R13L | NM_001142502.2 | c.*180T>C | 3_prime_UTR_variant | 13/13 | |||
PPP1R13L | XM_017026177.2 | c.*180T>C | 3_prime_UTR_variant | 14/14 | |||
PPP1R13L | XM_017026178.2 | c.*180T>C | 3_prime_UTR_variant | 14/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPP1R13L | ENST00000360957.10 | c.*180T>C | 3_prime_UTR_variant | 13/13 | 1 | NM_006663.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0163 AC: 2482AN: 152116Hom.: 71 Cov.: 31
GnomAD3 genomes
AF:
AC:
2482
AN:
152116
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00208 AC: 1093AN: 525254Hom.: 21 Cov.: 7 AF XY: 0.00174 AC XY: 483AN XY: 277842
GnomAD4 exome
AF:
AC:
1093
AN:
525254
Hom.:
Cov.:
7
AF XY:
AC XY:
483
AN XY:
277842
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0164 AC: 2502AN: 152234Hom.: 74 Cov.: 31 AF XY: 0.0159 AC XY: 1186AN XY: 74440
GnomAD4 genome
AF:
AC:
2502
AN:
152234
Hom.:
Cov.:
31
AF XY:
AC XY:
1186
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 24, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at